P&g forecast prices will lead to company revenue recovery

Procter & gamble, said yesterday that the recently due to lower product prices, and for the new version of its consumer product launch add more value, so this autumn revenue is expected to start to recover. Procter & gamble, said prescription drugs cause this fiscal revenue will increase to cents per share, they expect month to month basic sales growth in the quarter to % %. Procter & gamble basic sales - — Excluding acquisition related sales - — Consecutive quarter of decline, p&g this season is expected to flat or even falling %. Household spending cuts due to the recession, the United States, and to buy cheap brand, tumbled procter & gamble's sales performance. P&g management said, they are under the adjustment of the price of global product portfolio, price about %, and increases product 'value' to attract customers. Procter & gamble, said cut Cheer is the price of detergent, and test launch low tide detergent 'basic'. Procter & gamble's chief financial officer Jon Moeller said the company doesn't expect market conditions will get better, just think investments in research and development, marketing and pricing helps save revenue. P&g also said, announced last month for the price of $sell its global pharmaceutical enterprise give birth control pills and acne drug makers Warner Chilcott WCRX, the deal makes the full-year earnings per share. To the dollar. The dollar, analysts expected a share. The dollar. Range before the deal, analysts expect full-year earnings per share. To the dollar. The dollar.